Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

NCT01696617 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Aripiprazole 6-week group
DRUG: Aripiprazole 8-week group

Sponsor

Seoul National University Hospital

Collaborators

[object Object]